The Future of Gene Editing Panel

January 26 2017

The emergence of CRISPR as a catalyst for gene editing has hurled open a door to new advances in biotechnology and medicine. While the scientific community has been debating and applying CRISPR in various lab settings, the transition to real-world applications is imminent, taking place with no clear policy on guidelines or even potential restrictions.

• What is Our Goal?

  "The Future of Gene Editing" will be a multi-disciplinary panel discussion on policy considerations for gene editing implementation, with emphasis on long term societal implications -- 10, 20 or even 30 years into the future. It will build upon discussions started by the National Academy of Sciences, with the aim to:

  • Delve into the long-term considerations of genetic engineering -- where it is going, the challenges it will face, and the role of society as a whole in its development and regulation.

  • Bring some of the most relevant voices in the field to New York City.

  • Provide the local academic, industry, and policy community with an opportunity to actively participate in the discussion.

  Speakers

• Jamie Metzl

  Senior Fellow
  Atlantic Council

• Roberto Barbero

  Former Assistant Director,
  Biological Innovation
  White House OSTP

• S. Matthew Liao

  Director, Center for Bioethics
  New York University

• Marnie Gelbart

  Director of Programs, Personal Genetics Education Project, Harvard